Cytonics Corporation reposted this
President & CEO of Cytonics | Johns Hopkins School of Medicine | Moving From Insurmountable Challenge To Almost Certain Failure With Unbridled Enthusiasm
💣 Critical Mass Achieved. We're thrilled to share that #Cytonics has been making tremendous strides! Here's a glimpse of the exciting developments happening behind the scenes… ✅ Phase 1 Dosing Nearing Completion We’ve officially completed the first dose in our Phase 1 trial with very promising results – no adverse events reported! The final patient is set to receive their second (and last) dose this December, keeping us on track as we move closer to wrapping up this critical stage of #drugdevelopment. 🎥 Pro Athlete Power Couple & New Marketing Content Last week, we welcomed Rener and Eve Gracie (https://lnkd.in/eK7FTrWn, https://lnkd.in/eAcZGvae) to our clinic for their APIC treatments. These sessions will be filmed for an exciting new marketing video that showcases the power of our #FDA-cleared therapy. This #MMA power couple have joined Cytonics as major investors and our brand ambassadors. We can’t wait to share the new video with you all soon! 👥 Assembling The Osteoarthritis Dream Team In line with our mission to bring groundbreaking therapies to market, we’re expanding our Medical Advisory Board. We’ve successfully recruited 5 esteemed MD and PhD advisors (who have worked on a total of ~80 #osteoarthritis clinical studies!) and are finalizing the addition of a new Director. These individuals will be instrumental in shaping our clinical study design, enhancing our drug product strategy, and positioning Cytonics for a potential company exit. We can’t reveal all the details just yet, but trust us—this is huge! We’re preparing for a major press release that will highlight the caliber and influence of these new team members. Thank you to all of our investors for your continued support as we work to reshape the future of osteoarthritis treatment. Stay tuned for more updates—exciting things are on the horizon!